This combination was initially approved for PwCF carrying at least one p.Phe508del allele; however, theratyping efforts (i.e., matching modulators to responsive CFTR variants) led to label extension approval by the FDA to >170 CF-causing variants based on in vitro data [20,115]. Here, CFTR is linked to cystic fibrosis.